Coronavirus Revives Debate Over Drug Pricing


Not long ago, drug companies had a bull’s-eye on their ticker symbols. Sky-high prices for lifesaving drugs and the opioid crisis had made them the country’s least-liked industry. Democratic presidential candidates were one-upping each other with promises to rein in prices, while President Trump mulled similar plans.

Covid-19 has given drug companies a shot at redemption. They are pouring resources into therapies and vaccines, with the entire economy’s fate resting on their success.

Source link